Benjarin Santatiwongchai is Head of Communication for HITAP. Having studied BSc in Pharmacy from Mahidol University, her knowledge in current and emerging medical technologies and interventions has led her to become involved with Health Technology Assessment. In 2012, she completed her MSc in Health Economics at the University of York. She is now a

The attempt to provide public health insurance in Vietnam began since before the ‘Doi Moi’, an economic reform which happened in 1986, when health care activities were all supported by the government. After the reform, the structure of government support for health care changed to partial support. V

Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health through the International Decision Support Initiative (iDSI) has been working in Vietnam since 2014. iDSI has supported Ministry of Health (MOH) Vietnam in realising Universal Health Coverage (UHC) through a dif

This report aims to describe the study visit of researchers at Christian Medical College (CMC) Vellore who are undertaking cost of illness studies on enteric fever and rotavirus vaccines in India at the Health Intervention and Technology Assessment Program (HITAP). HITAP, known regionally for suppor

The Health Intervention and Technology Assessment Program (HITAP) has supported the development of Health Technology Assessment (HTA) in India by building technical capacity and knowledge through collaborations with several academic institutions in India on HTA. HITAP recently partnered with the Jaw

INTRODUCTION TO THE YEAR’S EVENTS 2015 was our best year yet – a year that saw our international Decision Support Initiative (iDSI) grow from a fledgling enterprise to a trusted source of knowledge and support for those setting healthcare priorities. With our iDSI partners in Thailand (HITAP),

Evidence-Based Decision-Making in Asia-Pacific with Rapidly Changing Health-Care Systems: Thailand, South Korea, and Taiwan. Thidaporn Jirawattanapisal1 Pritaporn Kingkaew2 Tae-Jin Lee3 Ming-Chin Yang4 1International Health Policy Program, Ministry of Public Health, Muang Nonthaburi,Thailand; 2

Criteria for priority setting of HIV/AIDS interventions in Thailand: a discrete choice experiment Sitaporn Youngkong*1,2, Rob Baltussen*1, Sripen Tantivess*2, Xander Koolman*3 and Yot Teerawattananon*2 1 Nijmegen International Center for Health Systems Research and Education (NICHE), Department of

Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand. Waranya Rattanavipapong1, Tanunya Koopitakkajorn1, Naiyana Praditsitthikorn1,2,*, Surakameth Mahasirimongkol3 andYot Teerawattananon1 Summary Purpose There is strong evidence o

Abstract Objectives In Thailand, axillary lymph node dissection (ALND) is the dominant form of treatment for breast cancer, even though the treatment often leaves patients with some degree of arm morbidity. Sentinel lymph node biopsy (SNB) is widely accepted globally as a preferable alternative pr